Microsatellite Genotyping of Candida parapsilosis Clinical Isolates
Current Medical Mycology, 2017 Background and Purpose: Candida parapsilosis is a predominant species found in nosocomial infection, particularly in hospitalized patients. The molecular epidemiology of the clinical strains of this species has not been well studied.
Hamid Badali +8 more
doaj +2 more sources
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS [PDF]
Mediterranean Journal of Hematology and Infectious Diseases, 2019 Background: This study aimed to identify the risk factors of candidemia and asses possible clinically significant differences between Candida parapsilosis and other candida species among cancer patients. Methods: A retrospective study was conducted in
Mingyue Sun +5 more
doaj +2 more sources
Antifungal Activity of Hedychium spicatum Essential Oil Against Candidemia-Causing Candida tropicalis and Candida parapsilosis: In Vitro Evaluation and Computational Identification of Cis-γ-Bisabolene as a Putative CYP51-Binding Constituent. [PDF]
Chem BiodiversHedychium spicatum essential oil (HSEO) exhibited concentration‐dependent antifungal activity against Candida parapsilosis and Candida tropicalis. GC‐MS identified 29 phytoconstituents, with τ‐cadinol as the major component. Computational analysis identified cis‐γ‐bisabolene as a promising CYP51 inhibitor, showing favorable binding, ADMET properties ...
Verma P, Baral DS, Verma R.
europepmc +2 more sources
In Vitro and In Silico Analysis of Antioxidant and Antifungal Activity of Essential Oil From Achillea biebersteinii. [PDF]
ChempluschemEssential oil of Achillea biebersteinii Afan. flowers exhibits moderate antioxidant activity in DPPH• and ABTS+ assays, while it demonstrates high anticandidal activity, with MFC (0.937−3.75 μL/mL) values. α‐Terpineol and trans‐Pinocarveol are antifungal compounds responsible for the effect against both C. glabrata and C.
Torun Z, Unver T, Alagoz MA.
europepmc +2 more sources
Characterization of Candida parapsilosis complex isolates [PDF]
, 2013 Candida parapsilosis former groups II and III have recently been established as independent species, named Candida orthopsilosis and Candida metapsilosis, respectively. We investigated the distribution of C.
Maite, Ruiz +3 more
core +2 more sources
Vaccines, 2023 Candida parapsilosis poses huge treatment challenges in the clinical settings of South Africa, and often causes infections among immunocompromised patients and underweight neonates.
Xiaolong Gong +4 more
doaj +1 more source
Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014. [PDF]
PLoS ONE, 2016 The Candida parapsilosis group encompasses three species: C. parapsilosis, C. orthopsilosis, and C. metapsilosis. Here, we describe the incidence and echinocandin susceptibility profile of bloodstream isolates of these three species collected from ...
Grazia Lovero +8 more
doaj +1 more source
Candida parapsilosis endocarditis: a comparative review of the literature [PDF]
, 2007 Fungal endocarditis (FE) is an uncommon disease, and while accounting for only 1.3-6% of all cases of infectious endocarditis, it carries a high mortality risk. Although Candida albicans represents the main etiology of FE, C.
Garzoni, C, Nobre, V A, Garbino, J
core +2 more sources
Journal of Fungi, 2023 Candidemia is the fourth most common healthcare-related bloodstream infection. In recent years, incidence rates of Candida parapsilosis have been on the rise, with differences in prevalence and antifungal susceptibility between countries.
Iacopo Franconi +4 more
doaj +1 more source
Mediators of Inflammation, 2010 This study was designed to investigate the interaction between C. parapsilosis and human epithelial cells using monolayer cultures and an engineered human oral mucosa (EHOM). C.
Raouf Bahri +3 more
doaj +1 more source